- Home
- MCN vs LFCR Comparison
MCN vs LFCR Comparison
Compare MCN & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCN | LFCR |
|---|---|---|
| Founded | 2004 | 1986 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4M | 143.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | MCN | LFCR |
|---|---|---|
| Price | $5.82 | $4.10 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 52.1K | ★ 545.8K |
| Earning Date | 01-01-0001 | 03-19-2026 |
| Dividend Yield | ★ 9.96% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $5.16 | $3.63 |
| 52 Week High | $6.39 | $8.98 |
Technical Indicators
Market Signals| Indicator | MCN | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 28.56 |
| Support Level | $5.65 | N/A |
| Resistance Level | $6.17 | $8.47 |
| Average True Range (ATR) | 0.08 | 0.29 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 61.11 | 37.77 |
Price Performance
Historical ComparisonAbout MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.